Cloning and expression of an anti-LDL(-) single-chain variable fragment, and its inhibitory effect on experimental atherosclerosis

References

• Kipriyanov SM, Le Gall F. Generation and production of engineered antibodies. Mol Biotechnol 2004; 26:39 - 60; http://dx.doi.org/10.1385/MB:26:1:39; PMID: 14734823
   PubMed Web of Science ®Google Scholar
• Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 2010; 10:301 - 16; http://dx.doi.org/10.1038/nri2761; PMID: 20414204
   PubMed Web of Science ®Google Scholar
• Reichert JM. Which are the antibodies to watch in 2013?. MAbs 2013; 5:1 - 4; http://dx.doi.org/10.4161/mabs.22976; PMID: 23254906
   PubMed Web of Science ®Google Scholar
• Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005; 23:1126 - 36; http://dx.doi.org/10.1038/nbt1142; PMID: 16151406
   PubMed Web of Science ®Google Scholar
• Shen Z, Yan H, Zhang Y, Mernaugh RL, Zeng X. Engineering peptide linkers for scFv immunosensors. Anal Chem 2008; 80:1910 - 7; http://dx.doi.org/10.1021/ac7018624; PMID: 18290668
   PubMed Web of Science ®Google Scholar
• Ahmad ZA, Yeap SK, Ali AM, Ho WY, Alitheen NBM, Hamid M. scFv antibody: principles and clinical application. Clin Dev Immunol 2012; 2012:980250; http://dx.doi.org/10.1155/2012/980250; PMID: 22474489
   PubMed Web of Science ®Google Scholar
• Quiroz FG, Sinclair SM. Engineering antibody fragments: replicating the immune system and beyond. Revista Ingenieria Biomedica 2010; 4:39 - 51
   Google Scholar
• Avogaro P, Bon GB, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988; 8:79 - 87; http://dx.doi.org/10.1161/01.ATV.8.1.79; PMID: 3341993
   PubMedGoogle Scholar
• Hulsmans M, Holvoet P. The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med 2010; 14:70 - 8; http://dx.doi.org/10.1111/j.1582-4934.2009.00978.x; PMID: 19968738
   PubMed Web of Science ®Google Scholar
• Bittolo-Bon G, Cazzolato G, Avogaro P. Probucol protects low-density lipoproteins from in vitro and in vivo oxidation. Pharmacol Res 1994; 29:337 - 44; http://dx.doi.org/10.1016/1043-6618(94)80055-3; PMID: 7971685
   PubMed Web of Science ®Google Scholar
• Sánchez-Quesada JL, Otal-Entraigas C, Franco M, Jorba O, González-Sastre F, Blanco-Vaca F, et al. Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 1999; 84:655 - 9; http://dx.doi.org/10.1016/S0002-9149(99)00411-7; PMID: 10498134
   PubMed Web of Science ®Google Scholar
• Sánchez-Quesada JL, Benítez S, Otal C, Franco M, Blanco-Vaca F, Ordóñez-Llanos J. Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects. J Lipid Res 2002; 43:699 - 705; PMID: 11971940
   PubMed Web of Science ®Google Scholar
• Sánchez-Quesada JL, Pérez A, Caixàs A, Rigla M, Payés A, Benítez S, et al. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification. J Clin Endocrinol Metab 2001; 86:3243 - 9; http://dx.doi.org/10.1210/jc.86.7.3243; PMID: 11443196
   PubMed Web of Science ®Google Scholar
• Mello AP, da Silva IT, Abdalla DS, Damasceno NR. Electronegative low-density lipoprotein: origin and impact on health and disease. Atherosclerosis 2011; 215:257 - 65; http://dx.doi.org/10.1016/j.atherosclerosis.2010.12.028; PMID: 21292266
   PubMed Web of Science ®Google Scholar
• Niccoli G, Bacà M, De Spirito M, Parasassi T, Cosentino N, Greco G, et al. Impact of electronegative low-density lipoprotein on angiographic coronary atherosclerotic burden. Atherosclerosis 2012; 223:166 - 70; http://dx.doi.org/10.1016/j.atherosclerosis.2012.04.005; PMID: 22640815
   PubMed Web of Science ®Google Scholar
• Faulin TES, Cavalcante MF, Abdalla DSP. Role of electronegative LDL and its associated antibodies in the pathogenesis of atherosclerosis. Clin Lipidol 2010; 5:719 - 29; http://dx.doi.org/10.2217/clp.10.52
   Web of Science ®Google Scholar
• Tiwari RL, Singh V, Barthwal MK. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev 2008; 28:483 - 544; http://dx.doi.org/10.1002/med.20118; PMID: 18000963
   PubMed Web of Science ®Google Scholar
• Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 2009; 27:165 - 97; http://dx.doi.org/10.1146/annurev.immunol.021908.132620; PMID: 19302038
   PubMed Web of Science ®Google Scholar
• Grosso DM, Ferderbar S, Wanschel ACBA, Krieger MH, Higushi ML, Abdalla DSP. Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-/- mice. Braz J Med Biol Res 2008; 41:1086 - 92; http://dx.doi.org/10.1590/S0100-879X2008001200007; PMID: 19148370
   PubMed Web of Science ®Google Scholar
• Peterson E, Owens SM, Henry RL. Monoclonal antibody form and function: manufacturing the right antibodies for treating drug abuse. AAPS J 2006; 8:E383 - 90; PMID: 16796389
   PubMed Web of Science ®Google Scholar
• Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM. Heterologous protein production using the Pichia pastoris expression system. Yeast 2005; 22:249 - 70; http://dx.doi.org/10.1002/yea.1208; PMID: 15704221
   PubMed Web of Science ®Google Scholar
• Tanfous NGB, Kallel H, Jarboui MA, Fathallah DM. Expression in Pichia pastoris of a recombinant scFv form of MAb 107, an anti human CD11b integrin antibody. Enzyme Microb Technol 2006; 38:636 - 42; http://dx.doi.org/10.1016/j.enzmictec.2005.07.014
   Web of Science ®Google Scholar
• Shi X, Karkut T, Chamankhah M, Alting-Mees M, Hemmingsen SM, Hegedus D. Optimal conditions for the expression of a single-chain antibody (scFv) gene in Pichia pastoris.. Protein Expr Purif 2003; 28:321 - 30; http://dx.doi.org/10.1016/S1046-5928(02)00706-4; PMID: 12699697
   PubMed Web of Science ®Google Scholar
• Eldin P, Pauza ME, Hieda Y, Lin G, Murtaugh MP, Pentel PR, et al. High-level secretion of two antibody single chain Fv fragments by Pichia pastoris.. J Immunol Methods 1997; 201:67 - 75; http://dx.doi.org/10.1016/S0022-1759(96)00213-X; PMID: 9032410
   PubMed Web of Science ®Google Scholar
• Heimo H, Palmu K, Suominen I. Human placental alkaline phosphatase: expression in Pichia pastoris, purification and characterization of the enzyme. Protein Expr Purif 1998; 12:85 - 92; http://dx.doi.org/10.1006/prep.1997.0808; PMID: 9473461
   PubMed Web of Science ®Google Scholar
• Sainz-Pastor N, Tolner B, Huhalov A, Kogelberg H, Lee YC, Zhu D, et al. Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. Int J Biol Macromol 2006; 39:141 - 50; http://dx.doi.org/10.1016/j.ijbiomac.2006.03.022; PMID: 16678252
   PubMed Web of Science ®Google Scholar
• Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993; 92:883 - 93; http://dx.doi.org/10.1172/JCI116663; PMID: 8349823
   PubMed Web of Science ®Google Scholar
• Pedrosa AMC, Faine LA, Grosso DM, de Las Heras B, Boscá L, Abdalla DSP. Electronegative LDL induction of apoptosis in macrophages: involvement of Nrf2. Biochim Biophys Acta 2010; 1801:430 - 7; http://dx.doi.org/10.1016/j.bbalip.2009.12.001; PMID: 20005974
   PubMed Web of Science ®Google Scholar
• Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem 2003; 278:1561 - 8; http://dx.doi.org/10.1074/jbc.M209634200; PMID: 12424240
   PubMed Web of Science ®Google Scholar
• Bae YS, Lee JH, Choi SH, Kim S, Almazan F, Witztum JL, et al. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res 2009; 104:210 - 8, 21p, 218; http://dx.doi.org/10.1161/CIRCRESAHA.108.181040; PMID: 19096031
   PubMed Web of Science ®Google Scholar
• Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med 2002; 8:1235 - 42; http://dx.doi.org/10.1038/nm1102-1235; PMID: 12411950
   PubMed Web of Science ®Google Scholar
• Burleigh ME, Babaev VR, Oates JA, Harris RC, Gautam S, Riendeau D, et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 2002; 105:1816 - 23; http://dx.doi.org/10.1161/01.CIR.0000014927.74465.7F; PMID: 11956125
   PubMed Web of Science ®Google Scholar
• Schönbeck U, Sukhova GK, Graber P, Coulter S, Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 1999; 155:1281 - 91; http://dx.doi.org/10.1016/S0002-9440(10)65230-3; PMID: 10514410
   PubMed Web of Science ®Google Scholar
• Maiwald S, Zwetsloot PP, Sivapalaratnam S, Dallinga-Thie GM. Monocyte gene expression and coronary artery disease. Curr Opin Clin Nutr Metab Care 2013; 16:411 - 7; PMID: 23739627
   PubMed Web of Science ®Google Scholar
• Chávez-Sánchez L, Chávez-Rueda K, Legorreta-Haquet MV, Zenteno E, Ledesma-Soto Y, Montoya-Díaz E, et al. The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1β, IL-6, and IL-10 secretion in human monocytes and macrophages. Lipids Health Dis 2010; 9:117; http://dx.doi.org/10.1186/1476-511X-9-117; PMID: 20946675
   PubMed Web of Science ®Google Scholar
• Schiopu A, Bengtsson J, Söderberg I, Janciauskiene S, Lindgren S, Ares MP, et al. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation 2004; 110:2047 - 52; http://dx.doi.org/10.1161/01.CIR.0000143162.56057.B5; PMID: 15451805
   PubMed Web of Science ®Google Scholar
• Tsimikas S, Miyanohara A, Hartvigsen K, Merki E, Shaw PX, Chou MY, et al. Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol 2011; 58:1715 - 27; http://dx.doi.org/10.1016/j.jacc.2011.07.017; PMID: 21982317
   PubMed Web of Science ®Google Scholar
• Nilsson J, Hansson GK, Shah PK. Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler Thromb Vasc Biol 2005; 25:18 - 28; PMID: 15514204
   PubMed Web of Science ®Google Scholar
• Brígido MM, Polymenis M, Stollar BD. Role of mouse VH10 and VL gene segments in the specific binding of antibody to Z-DNA, analyzed with recombinant single chain Fv molecules. J Immunol 1993; 150:469 - 79; PMID: 8419479
   PubMed Web of Science ®Google Scholar
• Andrade EV, Albuquerque FC, Moraes LMP, Brígido MM, Santos-Silva MA. Single-chain Fv with Fc fragment of the human IgG1 tag: construction, Pichia pastoris expression and antigen binding characterization. J Biochem 2000; 128:891 - 5; http://dx.doi.org/10.1093/oxfordjournals.jbchem.a022838; PMID: 11098129
   PubMed Web of Science ®Google Scholar
• Santo Faulin TdoE, de Sena KC, Rodrigues Telles AE, de Mattos Grosso D, Bernardi Faulin EJ, Parra Abdalla DS. Validation of a novel ELISA for measurement of electronegative low-density lipoprotein. Clin Chem Lab Med 2008; 46:1769 - 75; http://dx.doi.org/10.1515/CCLM.2008.333; PMID: 19055454
   PubMed Web of Science ®Google Scholar
• Coloma MJ, Larrick JW, Ayala M, Gavilondo-Cowley JV. Primer design for the cloning of immunoglobulin heavy-chain leader-variable regions from mouse hybridoma cells using the PCR. Biotechniques 1991; 11:152 - 4, 156; PMID: 1931008
   PubMed Web of Science ®Google Scholar
• Zhou H, Fisher RJ, Papas TS. Optimization of primer sequences for mouse scFv repertoire display library construction. Nucleic Acids Res 1994; 22:888 - 9; http://dx.doi.org/10.1093/nar/22.5.888; PMID: 8139934
   PubMed Web of Science ®Google Scholar
• Caldas C, Coelho VP, Rigden DJ, Neschich G, Moro AM, Brígido MM. Design and synthesis of germline-based hemi-humanized single-chain Fv against the CD18 surface antigen. Protein Eng 2000; 13:353 - 60; http://dx.doi.org/10.1093/protein/13.5.353; PMID: 10835109
   PubMedGoogle Scholar
• Brígido MM, Polymenis M, Stollar BD. Role of mouse VH10 and VL gene segments in the specific binding of antibody to Z-DNA, analyzed with recombinant single chain Fv molecules. J Immunol 1993; 150:469 - 79; PMID: 8419479
   PubMed Web of Science ®Google Scholar
• Andrade EV, Albuquerque FC, Moraes LMP, Brígido MM, Santos-Silva MA. Single-chain Fv with Fc fragment of the human IgG1 tag: construction, Pichia pastoris expression and antigen binding characterization. J Biochem 2000; 128:891 - 5; http://dx.doi.org/10.1093/oxfordjournals.jbchem.a022838; PMID: 11098129
   PubMed Web of Science ®Google Scholar
• Wung JL, Gascoigne NR. Antibody screening for secreted proteins expressed in Pichia pastoris.. Biotechniques 1996; 21:808 - , 810, 812; PMID: 8922617
   PubMed Web of Science ®Google Scholar
• Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89:271 - 7; http://dx.doi.org/10.1016/0022-1759(86)90368-6; PMID: 3486233
   PubMed Web of Science ®Google Scholar
• Terra X, Fernández-Larrea J, Pujadas G, Ardèvol A, Bladé C, Salvadó J, et al. Inhibitory effects of grape seed procyanidins on foam cell formation in vitro. J Agric Food Chem 2009; 57:2588 - 94; http://dx.doi.org/10.1021/jf803450a; PMID: 19292475
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402 - 8; http://dx.doi.org/10.1006/meth.2001.1262; PMID: 11846609
   PubMed Web of Science ®Google Scholar
• Via DP, Smith LC. Fluorescent labeling of lipoproteins. Methods Enzymol 1986; 129:848 - 57; http://dx.doi.org/10.1016/0076-6879(86)29108-9; PMID: 3724556
   PubMedGoogle Scholar
• Reeves PG, Nielsen FH, Fahey GC Jr.. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123:1939 - 51; PMID: 8229312
   PubMed Web of Science ®Google Scholar
• Daleprane JB, Freitas VdaS, Pacheco A, Rudnicki M, Faine LA, Dörr FA, et al. Anti-atherogenic and anti-angiogenic activities of polyphenols from propolis. J Nutr Biochem 2012; 23:557 - 66; http://dx.doi.org/10.1016/j.jnutbio.2011.02.012; PMID: 21764281
   PubMed Web of Science ®Google Scholar
• Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987; 68:231 - 40; http://dx.doi.org/10.1016/0021-9150(87)90202-4; PMID: 3426656
   PubMed Web of Science ®Google Scholar